Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B D Walker

Showing results (61-70 of 165) with videos related to

Pageof 17
Sort By:
Journal of Virology|September 12, 2000
Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulationS Le Gall, F Buseyne, A Trocha, et al.
Journal of Virology|October 3, 2001
Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infectionD C Montefiori, T S Hill, H T Vo, et al.
AIDS Research and Human Retroviruses|January 1, 1993
CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individualT J Curiel, J T Wong, P F Gorczyca, et al.
The Journal of Infectious Diseases|February 1, 1996
Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressorE Harrer, T Harrer, P Barbosa, et al.
Clinical Immunology and Immunopathology|January 1, 1995
Cytotoxic CD8+ T lymphocytes reactive with human immunodeficiency virus-1 produce granulocyte/macrophage colony-stimulating factor and variable amounts of interleukins 2, 3, and 4 following stimulation with the cognate epitopeP Price, R P Johnson, D T Scadden, et al.
The Journal of Experimental Medicine|October 1, 1994
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1T J Tsomides, A Aldovini, R P Johnson, et al.
Journal of Virology|May 1, 1993
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigensC Jassoy, T Harrer, T Rosenthal, et al.
The Journal of Infectious Diseases|October 7, 2000
Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in UgandaH Cao, I Mani, R Vincent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2001
Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibodyR P Walensky, E S Rosenberg, M J Ferraro, et al.
Journal of Immunological Methods|August 6, 1998
A mutant human beta2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptorsJ B Walter, D N Garboczi, Q R Fan, et al.
Pageof 17

Showing results (61-70 of 165) with videos related to

Sort By:
Pageof 17
Journal of Virology|September 12, 2000
Distinct trafficking pathways mediate Nef-induced and clathrin-dependent major histocompatibility complex class I down-regulationS Le Gall, F Buseyne, A Trocha, et al.
Journal of Virology|October 3, 2001
Neutralizing antibodies associated with viremia control in a subset of individuals after treatment of acute human immunodeficiency virus type 1 infectionD C Montefiori, T S Hill, H T Vo, et al.
AIDS Research and Human Retroviruses|January 1, 1993
CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individualT J Curiel, J T Wong, P F Gorczyca, et al.
The Journal of Infectious Diseases|February 1, 1996
Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressorE Harrer, T Harrer, P Barbosa, et al.
Clinical Immunology and Immunopathology|January 1, 1995
Cytotoxic CD8+ T lymphocytes reactive with human immunodeficiency virus-1 produce granulocyte/macrophage colony-stimulating factor and variable amounts of interleukins 2, 3, and 4 following stimulation with the cognate epitopeP Price, R P Johnson, D T Scadden, et al.
The Journal of Experimental Medicine|October 1, 1994
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1T J Tsomides, A Aldovini, R P Johnson, et al.
Journal of Virology|May 1, 1993
Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigensC Jassoy, T Harrer, T Rosenthal, et al.
The Journal of Infectious Diseases|October 7, 2000
Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in UgandaH Cao, I Mani, R Vincent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2001
Investigation of primary human immunodeficiency virus infection in patients who test positive for heterophile antibodyR P Walensky, E S Rosenberg, M J Ferraro, et al.
Journal of Immunological Methods|August 6, 1998
A mutant human beta2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptorsJ B Walter, D N Garboczi, Q R Fan, et al.
Pageof 17